FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating
Project aims to develop a scalable manufacturing process and represents a key next step toward the commercialization of the surface...
Antimicrobial
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease researchSUNNYVALE, Calif. and OXFORD, England, April 15,...
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems...
Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress
EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to...
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
FORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"),...
Imbed Biosciences Announces CMS Assignment of HCPCS Code A2040 for Microlyte® PainGuard™
Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain managementMIDDLETON, Wis.,...
Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets
CHICAGO, IL / ACCESS Newswire / April 1, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a...
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
Kane also signs U.S.-based contract sales agentsWINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the...
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG...
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across...
Clinical Microbiology Market on Track to Reach $9.7 Billion by 2033: Allied Market Research
The growing prevalence of infectious diseases, increasing antimicrobial resistance (AMR), and the rising demand for rapid diagnostic solutions are the...
disAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation, Investment, and Policy Alignment
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- disAMR, a new company formed by partners who built Brammer Bio and have worked...
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal
WINNIPEG, Manitoba, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE) (“Kane Biotech” or “Kane”) announces the publication...
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide...
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
Greenhouse trial results published jointly with USDA-ARS demonstrate 76-98% reduction in aflatoxin contamination in transgenic corn expressing the BioCypher-designed peptide...
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeutics Versatile platform technology developed from a...
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
NeuroThera’s Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- SciSparc...
Kirkman(R) Unveils Revolutionary L Reuteri: a Brain-Protective Probiotic with Immune Benefits
Lake Oswego, Oregon--(Newsfile Corp. - February 2, 2026) - Functional Brands Inc. (NASDAQ: MEHA), parent company of Kirkman®, a trusted...
SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)
This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J.,...